Skip to main content

Advertisement

SpringerLink
Log in

The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC)

  • Contrast Media
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this retrospective study was to investigate the incidence of contrast-induced nephropathy (CIN) caused by transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC).

Materials and Methods

One hundred forty-one patients treated between 2005 and 2008 undergoing 305 consecutive sessions of TACE were enrolled. CIN was defined as an increase in the serum creatinine level of more than 0.5 mg/dl or more than 25 % from baseline within 3 days after TACE without any other identifiable cause of acute kidney injury.

Results

CIN by the present definition was observed after 2.6 % of the TACE sessions. No patient showed clinical signs or symptoms of acute renal failure, or required haemodialysis. None of the patients with an estimated glomerular filtration rate of <60 ml/min/1.73 m2 developed CIN.

Conclusion

The present study suggests that TACE is a relatively safe procedure in terms of the risk of CIN under vigorous periprocedural hydration and that the incidence of CIN is comparable to that of AKI associated with intravenous CM administration.

Key points

• CIN would be lower for non-coronary arterial intervention than for coronary intervention.

• The present study suggests that the CIN rates following TACE are low.

• The incidence of CIN is comparable to that after intravenous CM administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541

    Article  PubMed  Google Scholar 

  2. Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264

    Article  PubMed  Google Scholar 

  3. Lindsay J, Canos DA, Apple S et al (2004) Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatinine kinase-MB versus rise of serum creatinine. Am J Cardiol 94:786–789

    Article  CAS  PubMed  Google Scholar 

  4. Taliercio CP, Vlietstra RE, Fisher LD et al (1986) Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104:501–504

    Article  CAS  PubMed  Google Scholar 

  5. Chou SH, Wang ZJ, Kuo J et al (2011) Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration. Eur J Radiol 80:378–386

    Article  PubMed Central  PubMed  Google Scholar 

  6. Lufft V, Lufft LH, Fels LM et al (2002) Contrast media nephropathy: Intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Am J Kidney Dis 40:236–242

    Article  PubMed  Google Scholar 

  7. Ahuja TS, Niaz N, Agraharkar M (2000) Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 54:11–14

    CAS  PubMed  Google Scholar 

  8. Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implication of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548

    Article  CAS  PubMed  Google Scholar 

  9. Sharma SK, Kini A (2005) Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: Pooled analysis of the randomized trials. Cathet Cardiovasc Interv 65:386–393

    Article  Google Scholar 

  10. Solomon RJ, Natarajan MK, Doucet S et al (2007) Cardiac angiography in renally impaired patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115:3189–3196

    Article  PubMed  Google Scholar 

  11. Loh Y, McArthur DL, Vespa P et al (2010) The risk of acute radiocontrast-mediated kidney injury following endovascular therapy for acute ischemic stroke is low. Am J Neuroradiol 31:1584–1587

    Article  CAS  PubMed  Google Scholar 

  12. Kato T, Sakai H, Tsujimoto M, Nishimura Y (2011) Prolonged carotid sinus reflex is a risk factor for contrast-induced nephropathy following carotid artery stenting. Am J Neuroradiol 32:441–445

    Article  CAS  PubMed  Google Scholar 

  13. Huo TI, Wu JC, Huang YH et al (2004) Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: A retrospective study of the incidence, risk factors, clinical course and long-term outcome. Aliment Pharmacol Ther 19:999–1007

    Article  PubMed  Google Scholar 

  14. Huo TI, Wu JC, Chang FY, Lee SD (2004) Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int 24:210–215

    Article  PubMed  Google Scholar 

  15. Park J, Chung HC, Lee JS et al (2008) Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: A retrospective analysis. Blood Purif 26:454–459

    Article  PubMed  Google Scholar 

  16. Hsu CY, Huang YH, Su CH et al (2010) Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization. Liver Int 30:77–84

    Article  CAS  PubMed  Google Scholar 

  17. Hsu CY, Huang YH, Su CW et al (2010) Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency. J Clin Gastroenterol 44:e171–e177

    PubMed  Google Scholar 

  18. Cho HS, Seo JW, Kang Y et al (2011) Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. Clin Exp Nephrol 15:714–719

    Article  PubMed  Google Scholar 

  19. Lee YH, Hsu CY, Huang YH et al (2012) Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J Gastroenterol Hepatol 27:1581–1588

    Article  PubMed  Google Scholar 

  20. Katzberg RW, Newhouse JH (2010) Intravenous contrast medium-induced nephrotoxicity: Is the medical risk really as great as we have come to believe? Radiology 256:21–28

    Article  PubMed  Google Scholar 

  21. Katzberg RW, Barrett BJ (2007) Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 243:622–628

    Article  PubMed  Google Scholar 

  22. Tepel M, van der Geit M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184

    Article  CAS  PubMed  Google Scholar 

  23. Becker CR, Reiser MF (2005) Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography of patients with renal impairment. Invest Radiol 40:672–675

    Article  PubMed  Google Scholar 

  24. Barrett BJ, Katzberg RW, Thomsen HS et al (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computer tomography—a double blind comparison of iodixanol and iopamidol. Invest Radiol 41:815–821

    Article  CAS  PubMed  Google Scholar 

  25. Thomsen HS, Morcos SK, Earley CM et al (2008) The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 43:170–178

    Article  CAS  PubMed  Google Scholar 

  26. Kuhn MJ, Chen N, Sahani DV et al (2008) The PREDICT study: A randomized double-blind comparison of contrast-induced nephropathy after low- or iso-osmolar contrast agent exposure. Am J Roentgenol 191:151–157

    Article  Google Scholar 

  27. Nguyen SA, Suranyi P, Ravenel JG et al (2008) Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 248:97–105

    Article  PubMed  Google Scholar 

  28. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ (2008) Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 3:1274–1281

    Article  PubMed Central  PubMed  Google Scholar 

  29. Moreau R, Lebec D (2003) Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 37:233–243

    Article  PubMed  Google Scholar 

  30. Barrett BJ, Parfrey PS (1994) Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 331:1449–1450

    Article  CAS  PubMed  Google Scholar 

  31. Guevara M, Fernández-Esparrach G, Alessandria C et al (2004) Effect of contrast media in renal function in patients with cirrhosis: A prospective study. Hepatology 40:646–651

    Article  PubMed  Google Scholar 

  32. Najar M, Hamad A, Salameh M, Agarwal A, Feinfeld DA (2002) The risk of radiocontrast nephropathy in patients with cirrhosis. Ren Fail 24:11–18

    Article  Google Scholar 

  33. Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 267:94–105

    Article  PubMed Central  PubMed  Google Scholar 

  34. McDonald RJ, McDonald JS, Bida JP et al (2013) Intravenous contrast material-induced nephropathy: Causal or coincident phenomenon. Radiology 267:106–118

    Article  PubMed  Google Scholar 

  35. Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: Risk stratification by using estimated glomerular filtration rate. Radiology 268:719–728

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Kyoko Seiga for secretarial assistance and Richard W. Katzberg, MD, for his input and analysis of this manuscript.

The scientific guarantor of this publication is Dr. Ryota Fujimoto, who is now the Chairman of Department of Radiology, Kyoto City Hospital. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. No complex statistical methods were necessary for this article. Institutional Review Board approval was not required as this was a retrospective study. Written informed consent was obtained from all subjects (patients) in this study. None of the study subjects or cohorts have been reported previously. Methodology: retrospective, case-control study, performed at one institution.

Author information

Authors and Affiliations

  1. Department of Radiology, Kyoto City Hospital, 1-2 Higashi-takada-cho, Mibu, Nakagyo-ku, Kyoto, 604-8845, Japan

    Katsumi Hayakawa & Masato Tanikake

  2. Department of Gastroenterology, Kyoto, Japan

    Toshihiko Kirishima, Naomi Yoshinami & Hiroyuki Shintani

  3. Department of Surgery, Kyoto, Japan

    Eiji Yamamoto & Taisuke Morimoto

Authors
  1. Katsumi Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masato Tanikake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshihiko Kirishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naomi Yoshinami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroyuki Shintani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eiji Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Taisuke Morimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katsumi Hayakawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayakawa, K., Tanikake, M., Kirishima, T. et al. The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC). Eur Radiol 24, 1105–1111 (2014). https://doi.org/10.1007/s00330-014-3099-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-014-3099-8

Keywords

Search

Navigation